Utilizing the 2017–2018 seasonal influenza vaccine as a treatment for cancer
Autor: | Jenna H. Newman, Charles Brent Chesson, Salvatore Aspromonte, Praveen K. Bommareddy, Russell Pepe, Saeed Tarabichi, Shengguo Li, Sachin Jhawar, Nora L. Herzog, Mones Aboelatta, Eshan Kaul, Ricardo Estupinian, Michael P. Kane, Ann Silk, Andrew Zloza |
---|---|
Rok vydání: | 2018 |
Předmět: | |
Zdroj: | The Journal of Immunology. 200:178.44-178.44 |
ISSN: | 1550-6606 0022-1767 |
DOI: | 10.4049/jimmunol.200.supp.178.44 |
Popis: | In recent years, immunotherapy has yielded increased survival for cancer patients; however, a significant percentage of patient tumors remain refractory to immunotherapy. This is due in part to the absence of an inflamed tumor microenvironment. In our effort to utilize anti-pathogen vaccination to recruit immune cells to un-infiltrated (cold) tumors, we observed that intratumoral injection of influenza A/PR8/H1N1 lysate (but not live virus) reduced B16-F10 melanoma growth (p |
Databáze: | OpenAIRE |
Externí odkaz: |